Disclosed are methods and compositions for modulating cancer stem cells. More particularly the present invention discloses the use of protein kinase C theta inhibitors (PKC ) for inhibiting the growth of PKC overexpressing cells including cancer stem cells for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells for treating cancer including metastatic cancer and/or for preventing cancer recurrence.
